| Variables | HIV+ n (%) | Controls n (%) | Total n (%) | OR | 95% CI | p-value | |
| Gender |
|
|
|
|
|
| |
| # | Male | 51 (33.30) | 22 (13.70) | 73 (23.30) |
|
|
|
|
| Female | 102 (66.70) | 138 (86.30) | 240 (76.70) | 0.31 | 0.18 - 0.55 | <0.001* |
| Age (years) |
|
|
|
|
|
| |
| # | ≤39 | 28 (18.30) | 110 (68.70) | 138 (44.10) |
|
|
|
|
| ≥40 | 125 (81.70) | 50 (31.30) | 175 (55.90) | 9.82 | 5.78 - 16.66 | <0.001* |
| Serological status |
|
|
|
|
|
| |
|
| HIV+ | 153 (100.00) | 0 (0.00) | 153 (100.00) | - | - | - |
|
| HIV− | 0 (0.00) | 160 (100.00) | 160 (100.00) | - | - | - |
|
| HBV−/HCV− | 153 (100.00) | 160 (100.00) | 313 (100.00) | - | - | - |